GWM
SCMP

Gupta Wealth Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gupta Wealth Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$22K Hold
2,000
– – 0.01% 637
2015
Q4 		$35K Buy
+2,000
New +$35.9K 0.01% 514

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Gupta Wealth Management's SCMP Position: Q1 2016 in Review

Gupta Wealth Management held its Sucampo Pharmaceuticals, Inc. (SCMP) position steady in Q1 2016 at 2,000 shares worth $22K. The position accounts for 0.01% of the portfolio, ranked #637.

Gupta Wealth Management first reported a position in SCMP in Q4 2015 and has held it in 2 quarters since. The position peaked at $35K in Q4 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • Gupta Wealth Management held 2,000 shares of Sucampo Pharmaceuticals, Inc. worth $22K as of Q1 2016.
  • Gupta Wealth Management left its Sucampo Pharmaceuticals, Inc. share count unchanged in Q1 2016.
  • Sucampo Pharmaceuticals, Inc. made up 0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #637 holding.
  • Gupta Wealth Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and has held it in 2 quarters since.
  • Gupta Wealth Management's Sucampo Pharmaceuticals, Inc. position peaked at $35K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.